<VariationArchive VariationID="430608" VariationName="NM_032861.4(SERAC1):c.1643_1646dup (p.Leu550fs)" VariationType="Duplication" Accession="VCV000430608" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-03-17" DateCreated="2017-07-08" MostRecentSubmission="2024-02-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="423256" VariationID="430608">
      <GeneList>
        <Gene Symbol="SERAC1" FullName="serine active site containing 1" GeneID="84947" HGNC_ID="HGNC:21061" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="158109519" stop="158168262" display_start="158109519" display_stop="158168262" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="158530535" stop="158589311" display_start="158530535" display_stop="158589311" Strand="-" />
          </Location>
          <OMIM>614725</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_032861.4(SERAC1):c.1643_1646dup (p.Leu550fs)</Name>
      <CanonicalSPDI>NC_000006.12:158114826:AGATAG:AGATAGATAG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="158114826" stop="158114827" display_start="158114826" display_stop="158114827" variantLength="4" positionVCF="158114826" referenceAlleleVCF="A" alternateAlleleVCF="AAGAT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="158535858" stop="158535859" display_start="158535858" display_stop="158535859" variantLength="4" positionVCF="158535858" referenceAlleleVCF="A" alternateAlleleVCF="AAGAT" />
      </Location>
      <ProteinChange>L550fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032861.3" sequenceAccession="NM_032861" sequenceVersion="3" change="c.1643_1646dupATCT">
            <Expression>NM_032861.3:c.1643_1646dupATCT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.158535861_158535864dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.158535861_158535864dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.158114829_158114832dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.158114829_158114832dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032889.1" sequenceAccession="NG_032889" sequenceVersion="1" change="g.58451_58454dup">
            <Expression>NG_032889.1:g.58451_58454dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032861.4" sequenceAccession="NM_032861" sequenceVersion="4" change="c.1643_1646dup" MANESelect="true">
            <Expression>NM_032861.4:c.1643_1646dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_116250.3" sequenceAccession="NP_116250" sequenceVersion="3" change="p.Leu550fs">
            <Expression>NP_116250.3:p.Leu550fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_073096.2" sequenceAccession="NR_073096" sequenceVersion="2" change="n.1558_1561dup">
            <Expression>NR_073096.2:n.1558_1561dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA4071010" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="614725.0008" DB="OMIM" />
        <XRef Type="rs" ID="761964407" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_032861.4(SERAC1):c.1643_1646dup (p.Leu550fs) AND 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome" Accession="RCV000494711" Version="7">
        <ClassifiedConditionList TraitSetID="8743">
          <ClassifiedCondition DB="MedGen" ID="C4040739">3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-07-03" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-07-03" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-07-08" MostRecentSubmission="2024-02-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28778788</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8743" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17318" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome</ElementValue>
                <XRef ID="MONDO:0013875" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-METHYLGLUTACONIC ACIDURIA, TYPE VI</ElementValue>
                <XRef Type="MIM" ID="614739" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MEGDEL syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MEGDEL</ElementValue>
                <XRef Type="MIM" ID="614739" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MGCA6</ElementValue>
                <XRef Type="MIM" ID="614739" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of SERAC1 deficiency comprises MEGD(H)EL syndrome (3-methylglutaconic aciduria with deafness-dystonia, [hepatopathy], encephalopathy, and Leigh-like syndrome), juvenile-onset complicated hereditary spastic paraplegia (in 1 consanguineous family), and adult-onset generalized dystonia (in 1 adult male). MEGD(H)EL syndrome is characterized in neonates by hypoglycemia and a sepsis-like clinical picture for which no infectious agent can be found. During the first year of life feeding problems, failure to thrive, and/or truncal hypotonia become evident; many infants experience (transient) liver involvement ranging from undulating transaminases to prolonged hyperbilirubinemia and near-fatal liver failure. By age two years progressive deafness, dystonia, and spasticity prevent further psychomotor development and/or result in loss of acquired skills. Affected children are completely dependent on care for all activities of daily living; speech is absent.</Attribute>
                <XRef ID="NBK195853" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12963" />
                <XRef ID="12963" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24741715</ID>
                <ID Source="BookShelf">NBK195853</ID>
              </Citation>
              <XRef ID="352328" DB="Orphanet" />
              <XRef ID="C4040739" DB="MedGen" />
              <XRef ID="MONDO:0013875" DB="MONDO" />
              <XRef Type="MIM" ID="614739" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1137151" SubmissionDate="2017-07-05" DateLastUpdated="2017-07-08" DateCreated="2017-07-08">
        <ClinVarSubmissionID localKey="SUB2518498" submittedAssembly="not applicable" title="SUB2518498" />
        <ClinVarAccession Accession="SCV000537857" DateUpdated="2017-07-08" DateCreated="2017-07-08" Type="SCV" Version="1" SubmitterName="Yoda Diagnostics Pvt Ltd, YODA Diagnostics Pvt Ltd" OrgID="506142" OrganizationCategory="laboratory" OrgAbbreviation="YODA" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Observed in a female patient who developed severe respiratory distress due to severe metabolic acidosis. Serum lactate, transaminases and serum bilirubin elevated. Subsequent follow up at 15 months of age revealed gross psychomotor delay with dystonia with urine organic acid analysis showing 7-fold increase in methylglutaconic acid and 2-fold increase in 3-methyl glutaric acid levels. The patient was re-evaluated at 7 years of age. At this age, the patient manifested seizures, generalized dystonia, failure to thrive, swallowing difficulty, spasticity and flexion contractures.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Dravidian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Sequence alignment</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="Human Phenotype Ontology" ID="HP:0000252" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="Human Phenotype Ontology" ID="HP:0002098" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="Human Phenotype Ontology" ID="HP:0005967" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SERAC1">
              <Name>serine active site containing 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032861.3:c.1643_1646dupATCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614739" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2518498</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3956843" SubmissionDate="2021-11-17" DateLastUpdated="2021-11-20" DateCreated="2021-11-20">
        <ClinVarSubmissionID localKey="614725.0008_3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME" title="SERAC1, 4-BP DUP, 1643ATCT_3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME" />
        <ClinVarAccession Accession="SCV002016240" DateUpdated="2021-11-20" DateCreated="2021-11-20" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an Indian patient, born to consanguineous parents, with 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome (MEGDEL; 614739), Rama Devi and Lingappa (2018) identified homozygosity for a 4-bp duplication (c.1643_1646dupATCT, NM_032861.3) in exon 15 of the SERAC1 gene, predicted to result in a frameshift and premature termination (Leu550fsTer19). The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, was present in heterozygous state in the parents. The mutation was not present in the 1000 Genomes Project database and was present in the ExAC database at a minor allele frequency of 0.02%. The patient had a history of neonatal hepatopathy and metabolic acidosis, developmental delay, and dystonia. Urine organic acid analysis in the patient showed elevations of 3-methylglutaconic and 3-methylglutaric acids.</Attribute>
              <Citation>
                <ID Source="PubMed">28778788</ID>
              </Citation>
              <XRef DB="OMIM" ID="614739" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SERAC1" />
          </GeneList>
          <Name>SERAC1, 4-BP DUP, 1643ATCT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DUP, 1643ATCT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614725.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3961643" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="e7e982bf757b2dc7e00a6d1e93a6c621de7b05bcbc955f3e81c3febd0a7fc196|OMIM:614739" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002020067" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032861.3:c.1643_1646dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614739" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3961643" TraitType="Disease" MappingType="XRef" MappingValue="614739" MappingRef="OMIM">
        <MedGen CUI="C4040739" Name="3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1137151" TraitType="Finding" MappingType="XRef" MappingValue="HP:0005967" MappingRef="Human Phenotype Ontology">
        <MedGen CUI="C1840372" Name="Mixed respiratory and metabolic acidosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1137151" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002098" MappingRef="Human Phenotype Ontology">
        <MedGen CUI="C0476273" Name="Respiratory distress" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1137151" TraitType="Disease" MappingType="XRef" MappingValue="614739" MappingRef="OMIM">
        <MedGen CUI="C4040739" Name="3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1137151" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000252" MappingRef="Human Phenotype Ontology">
        <MedGen CUI="C4551563" Name="Microcephaly" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

